Previous Article | Next Article ![]()
Journal of Bacteriology, April 2003, p. 2618-2627, Vol. 185, No. 8
0021-9193/03/$08.00+0 DOI: 10.1128/JB.185.8.2618-2627.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
INSERM U570, Faculté de Médecine Necker-Enfants Malades, Université René Descartes, Paris, France
Received 23 September 2002/ Accepted 8 January 2003
|
|
|---|
|
|
|---|
Neisseria meningitidis and Neisseria gonorrhoeae are two closely related pathogens. N. meningitidis, a normal inhabitant of the human nasopharynx (R. J. Sim, M. M. Harrison, E. R. Moxon, and C. M. Tang, Letter, Lancet 356:1653-1654, 2000), has the ability, in a small proportion of those colonized, to invade the epithelium, to disseminate within the bloodstream, and to cross the blood-brain barrier. On the other hand, N. gonorrhoeae colonizes and invades the urogenital tract to cause a localized inflammation, gonorrhoea. In both cases the ability to interact with host cells plays a major role in the ability of these bacteria to establish a productive infection. Numerous bacterial attributes have been identified as playing a role in these interactions. Among these, the type IV pili (TFP) play an essential role by allowing the initial adhesion of bacteria with host cells. TFP are believed to mediate adhesion via the adhesin PilC1. We have previously shown that the expression of PilC1 is upregulated during the initial interaction of the bacteria with the cells and that this upregulation is required for a complete adhesiveness mediated by TFP (30). This regulation of the expression of PilC1 is controlled by a 130-bp sequence located upstream of pilC1. Further analysis demonstrated that a 130-bp sequence identical to that found upstream of pilC1 was also present upstream of another ORF designated crgA (4). This 130-bp sequence is also responsible for the upregulation of crgA during the initial contact of the bacterium with the host cell. This 130-bp element was subsequently designated CREN, for contact regulatory element of Neisseria (4).
In this work we demonstrate that the CREN located upstream of pilC1 and crgA correspond to REP2 and that 14 out of the 16 ORFs located downstream of REP2 are upregulated during the initial contact of the bacteria with the cells in a manner similar to that of pilC1 and crgA. This suggests that these 14 REP2-associated genes are coordinately upregulated during the initial interaction of N. meningitidis with the host cells. In an attempt to identify the function of these genes during the bacterial host-cell interaction, we subsequently engineered mutations in all these genes.
|
|
|---|
The sequence of N. meningitidis Z2491 (20) was obtained from the Sanger Center (http://www.sanger.ac.uk/Projects/N_meningitidis/). The sequence of N. meningitidis MC58 (31), a serogroup B isolate, was obtained from The Institute of Genomic Research (http://tigrblast.tigr.org/pub/data/n_meningitidis/). The sequence of N. gonorrhoeae FA1090, an N. gonorrhoeae isolate, was from the University of Oklahoma (http://www.genome.ou.edu/gono.html) and corresponds to the 25 February 2001 release. BLAST searches were performed using BLASTN and the default parameter of each web site.
Antibodies. Phalloidin-Alexa-488 (Molecular Probes, Eugene, Oreg.) was used to stain the actin cytoskeleton (F-actin). Ezrin was detected using selective rabbit polyclonal antisera kindly provided by P. Mangeat (CNRS, Montpellier, France). In infected monolayers, bacteria were stained using a rabbit polyclonal antibody directed against the meningococcus strain Rou (5). The 20D9 monoclonal antibody recognizes the SB pilin variant produced by 2C43 (22). The antibody used to detect PilC1 protein in Western blot analysis was 18P4 (17).
Cell culture and infection. Human umbilical vein endothelial cells (HUVECs) (promoCell) were used between passages 1 and 8 and grown in Endo-SFM supplemented with 10% heat-inactivated fetal calf serum (FCS) and 2 mM L-glutamine (Life Technologies), basic fibroblast growth factor (1 ng/ml; Boehringer-Mannheim), heparin (0.5 IU/ml), and endothelial cell growth supplement (1.25 µg/ml) (Sigma). HEC1-B is a human endometrial adenocarcinoma cell line obtained from the American Type Culture Collection and was grown in Dulbecco' modified Eagle medium-Glutamax (Life Technologies) supplemented with 10% heat-inactivated FCS. Cells were seeded at 5 x 104 cells/cm2 in a 24-well culture plate and grown at 37°C in a humidified incubator under 5% CO2 for 2 to 3 days.
Bacteria for RNA preparations were obtained from monolayers infected with 106 bacteria in exponential growth phase. Bacteria were left in contact with the cells for 30 min, the supernatant was then removed, and the wells were gently washed with infection media (RPMI 1640 medium with Glutamax [Life Technologies] supplemented with 10% heat-inactivated FCS). Monolayers were then washed every hour and fresh medium was added. The monolayers were harvested at different time points.
Unless otherwise stated, when the aim of the experiment was to quantify adhesiveness, cells were infected with 105 bacteria in exponential growth phase and left without replacement of the supernatant. The percentage of cell-associated CFU was then determined after 2 and 4 h of infection.
Immunofluorecence and subsequent analysis using confocal microscopy were performed as previously described (5).
RNA extraction.
Bacteria were added to tubes at 65°C containing 700 µl of Trizol reagent (Lifetech) and
50 µl of acid-washed glass beads. The mix was vortexed vigorously and freeze-thawed using dry ice. Chloroform (200 µl) was added, and the contents were mixed by vortexing. The tubes were centrifuged at 15,000 x g for 15 min at 4°C, and the aqueous phase was taken and reextracted once before precipitation by addition of 1 volume of isopropanol. The RNA pellet was washed with 75% ethanol, dried, and redissolved in RNase-free TE buffer (10 mM Tris-HCl, 1 mM EDTA-Na [pH 8.0]). DNA was removed by addition of 1 µl of DNase I (Takara) and incubation for 30 min at 37°C, followed by inactivation at 70°C for 10 min. The complete removal of DNA was checked by the absence of signal in a PCR run on the RNA sample.
Real-time PCR assays. Oligonucleotides were designed using the Primer Express software (PE Applied biosystems) to obtain amplicons from the same size. Reverse transcription was performed using the 3'-oligonucleotides of the genes and the superscript TM II reverse transcriptase (Lifetech): 50 min at 45°C and 10 min at 70°C. Reverse transcription products were diluted to 1/10 and 1/100.
Real-time PCR was run on an ABI Prism 7700 sequence detection system (Perkin-Elmer Biosystems) using SYBR Green PCR Master Mix (PE Biosystems), according to the manufacturer's instructions.
Data analyses for a relative quantification of gene expression were performed by the comparative Ct (threshold cycle) method according to the manufacturer's instructions (user bulletin 2 for the ABI PRISM sequence detection system) and published data (27). The parameter Ct is defined as the cycle number at which fluorescence (which is proportional to the quantity of DNA in the tube during the exponential phase of the PCR) passes the fixed threshold. The relative amount of target, normalized to an endogenous reference (kanamycin resistance gene aphA3 inserted in a non coding region) is given by 2(Ctgene - CtaphA3). The induction factor is then the ratio of the amount of target in different conditions: 2(Ctgene - CtaphA3) infection media/2(Ctgene - CtaphA3).
Experiments were carried out four times. Freshly extracted RNA was used each time. Dilutions of the reverse transcription product were loaded in duplicate for each oligonucleotide couple in every experiments.
The statistical method used to test whether differences observed were significant was the Student test. Differences were considered as significant when P was <0.05.
Construction of mutants. Mutants were engineered either by in vitro transposition mutagenesis as previously described (21) or by insertion of a spectinomycin resistance cassette into an appropriate restriction site (12). Confirmation of the mutation was performed using PCR and Southern blotting. The precise insertion site of the mutant engineered by in vitro transposition was determined by sequencing.
Transformation of N. meningitidis. Bacteria grown overnight were resuspended in GC liquid medium containing 5 mM MgCl2 (transformation buffer) so that a 1/10 dilution of this suspension reached an optical density of 0.5 at 550 nm. Aliquots (200 µl) of this bacterial suspension were transferred into the wells of a 24-well tissue culture plate, and approximately 1 µg of DNA was added. These transformation mixtures were incubated for 30 min at 37°C. Then, 1.8 ml of prewarmed transformation buffer was added, and incubation was continued for 2 h at 37°C. Bacteria were then plated onto medium containing the appropriate antibiotic.
|
|
|---|
54 dependent promoter (1, 32). Though the rpoN gene is inactive in both N. meningitidis and N. gonorrhoeae (13), this promoter has been shown to play a major role in the cell contact regulation of both pilC1 and crgA (4, 29). |
View this table: [in a new window] |
TABLE 1. REP2 located upstream of an ORF in the Neisseria genome Z2491
|
![]() View larger version (80K): [in a new window] |
FIG. 1. (A) ClustalW alignment of the nucleotidic sequences of REP2. Each REP2 has been assigned a number. Identities are shaded. REP2-2 and REP2-3 correspond to the CREN upstream of crgA and pilC1, respectively. The ribosome binding site (AAGGA) and the predicted start codon are in boldface italic type and are underlined in the consensus sequence. The GG-N8-(A/G)C motif which is very close to the -24/-12 consensus characteristic of a 54-dependent promoter is boxed. The transcription starting point of crgA (P2) and pilC1 (PC1.3 and PC1.2) are outlined with an arrow (4, 29). (B) Phylogenetic analyses of REP2 sequences. The method used is the unweighted pair group method with arithmetic mean. The method for estimating DNA distances is p-distance. Numbers in boldface type are those assigned to each REP2. The numbers corresponding to pilC1 and crgA are underlined. Other numbers are distances between sequences.
|
|
View this table: [in a new window] |
TABLE 2. Cell contact induction of the transcription of REP2-associated genes
|
Role of the cell contact regulated REP2-associated genes in meningococcus-cell interaction. Considering the above results, we first hypothesized that some of the REP2-associated ORFs could be directly involved in the initial localized adhesion step. We therefore engineered mutations in all these genes as reported in Table 3. Mutations were obtained for all genes excepting three (NMA0812 secD, NMA1802 parC, and NMA2210 mviN), though numerous attempts were performed, thus suggesting that these ORFs may be encoding proteins essential for bacterial survival. In order to avoid possible phenotypic modifications due to phase or antigenic variation each mutation was reintroduced after amplification of the mutated sequence into the same genetic background. The correct replacement was then confirmed both by amplification of the mutated gene and Southern blotting.
|
View this table: [in a new window] |
TABLE 3. Construction of mutants in REP2-associated genes induced during initial cell contact
|
|
View this table: [in a new window] |
TABLE 4. Adhesion of mutants in REP2-associated genesa
|
![]() View larger version (106K): [in a new window] |
FIG. 2. Actin and ezrin recruitment visualized by confocal examination of infected monolayers of HUVECs. HUVECs were infected with either wild-type bacteria (Z5463) or mutants. Experiments were carried out after 4 h of infection (localized adhesion). The localization of bacterial colonies is shown in the first column by phase contrast. F-actin was labeled with a phalloidin probe (second column) and with ezrin by using a polyclonal antibody (third column). Results obtained with the wild-type strain and three of the mutants are shown. Similar results were obtained with the remaining seven mutants.
|
![]() View larger version (82K): [in a new window] |
FIG. 3. Confocal examination of infected HUVEC monolayers. HUVECs were infected with either wild-type bacteria (2C43) or the crgA:Sp mutant. Confocal microscopy was performed after 4 h (initial adhesion) and 6 h (beginning of diffuse adhesion when pili are already lost) of infection. A polyclonal antibody directed against N. meningitidis ROU was used to reveal bacteria (blue). F-actin was labeled with a phalloidin probe (green), and pilin was labeled by the monoclonal antibody 20D9 (red). Cell-associated CFU are piliated at 4 h and mostly nonpiliated at 6 h.
|
![]() View larger version (22K): [in a new window] |
FIG. 4. Adhesion of 2C43 and various crgA mutants on HUVECs. Cells were infected for 30 min with 105 bacteria in exponential growth phase and then washed. The monolayer was washed every hour. At different time points, monolayers were harvested and the number of adhesive bacteria was determined. 2C43 is the wild-type bacterium, NM98-3 is the previously described crgA mutant of 2C43 (4), crgA:Sp is the crgA mutant that we engineered in 2C43, 2C43+NM98-3 DNA corresponds to the strain 2C43 transformed with the total chromosomal DNA of NM98-3, 2C43+NM98-3 PCR corresponds to a transformant of strain 2C43 with the PCR product of the crgA mutation of NM98-3, and NM98-3 PilC1-enriched corresponds to cell-associated CFU of NM98-3 after 3 h of infection.
|
|
View larger version (18K): [in a new window] |
FIG. 5. Western blot analysis of PilC1. Lane 1, wild-type strain 2C43; lane 2, NM98-3; lane 3, cell-associated CFU of NM98-3 obtained after 1 h of infection; lane 4, cell-associated CFU of NM98-3 obtained after 3 h of infection; lane 5, cell-associated CFU of NM98-3 obtained after 8 h of infection; lane 6, 2C43 crgA:Sp. The antibody used to detect PilC proteins is 18P4 (17). Each well was loaded with similar amounts of protein.
|
|
|
|---|
54 (rpoN), and the absolute requirement for a transcriptional regulatory protein to activate the expression of the associated genes. The gene rpoN has been shown to be inactive in the pathogenic neisseriae (13) but the conserved -24(GG)/-12(GC) consensus sequence is involved in the regulation of pilE by PilA in N. gonorrhoeae (28). Moreover, PilA has been shown to be implicated in the induction of pilC1 upon cell contact by interacting directly with the CREN (29, 30). REP2 also share a ribosome-binding site: AAGGA localized 5 to 13 bases before a potential translational start codon ATG. A BLASTN analysis of the other two available neisserial genomic sequences reveals that REP2 sequences are present 22 and 23 times in N. meningitidis MC58 and N. gonorrhoeae FA1090, respectively, and are often localized upstream of ORFs, suggesting a potential role in transcription. The 130 bp upstream of pilC1 and crgA have been named CREN because they are implicated in the regulation of these genes upon cell contact. The 12 REP2-associated genes which are upregulated during the localized adhesion may correspond to other CRENs. Nine REP2-asociated genes were induced 2- to 6-fold, and three were induced over 15-fold. This difference may be due to the length or to the small differences in repeated sequences (addition, deletion, or modification of bases) that could modify the fixation of regulatory elements. Differences may also be attributable to other factors, such as regulatory motifs upstream of the repeats. For example, upstream of the CREN of pilC1 and crgA are found a variable number of T-N11-A motifs (4) which are binding sites for LysR family transcriptional regulators (26). Another explanation for the different induction levels observed is the mRNA stability. Indeed, mRNA processing and degradation by nucleases depends on their secondary structure, including the presence of stem loops at their 5' ends (9), the existence of terminators and of repetitive extragenic palindromic sequences at their 3' ends (10). Our data suggest that the REP2-associated genes which are regulated during the localized adhesion of N. meningitidis are part of a regulon.
Many other genes are certainly modified by contact with cells. A recent report investigating expression changes in N. meningitidis MC58 during interaction with human epithelial cells (16HBE14) revealed that 139 genes are upregulated more than twofold in one of the four time points tested and 55 genes exhibited a difference of more than fourfold (8). Our data are essentially in agreement with these results since some REP2-associated genes were among those 139 genes. However, the large number of genes found to be induced during the interaction with the cells indicate that other regulatory pathways, independent from the one which control the REP2-associated genes, exist. The REP2-associated genes upregulated during the cell contact are one of the regulons which control the meningococcal cell interaction.
The absence of modification of the bacterium-cell interaction observed in strains carrying mutations in one of the REP2-associated genes, apart from PilC1, does not exclude the possibility that these genes are involved in the interaction of the bacteria with host cells. It is possible that subtle changes in behavior of the bacteria may be required for optimal interaction with cell. Indeed, some of the REP2-associated genes could play a role in adaptation of the bacteria to grow on cells, such as the exodeoxyribonuclease xseB, or the topoisomerase parC, or the export protein secD. Equally, it will be important to investigate trans-acting regulatory elements that might coordinate the response of this regulon.
It is interesting to speculate on the evolutionary mechanisms leading to the association of REP2 with ORFs, in view of its function as a regulatory element. Since REP2 sequences are very homologous along their entire length, it seems unlikely that they have evolved separately as promoter sequences before a subset of genes. Rather, they have probably been inserted several times in the neisserial genomes. In support of this hypothesis REP2 precede many genes common to the N. meningitidis and N. gonorrhoeae genomes, but in some cases the same gene is preceded by a REP2 in one strain but not others. The mechanisms of insertion or duplication of many of the repeat sequences in the neisserial genome remain unclear, but the distribution of REP2 sequences in each of the genomes may provide a preliminary indication. The REP2 elements show a distinct preference for the lagging strand (Fig. 6) in contrast to the modest preference of gene polarity for the leading strand, hence suggesting a possible link between chromosomal replication and duplication/insertion of the REP2. Because of the high rates of genetic recombination in the pathogenic Neisseria species, to maintain such a strand preference the process of association of genes with REP2 elements should be an ongoing process. It is then possible that these insertions have been and are being subjected to evolutionary selection. Those conferring a benefit to the bacterium would be maintained (e.g., PilC1), while neutral changes will be seen in only some strains (for example mviN) and unfavorable insertions will be lost due to their host bacteria being nonviable or less competitive.
![]() View larger version (28K): [in a new window] |
FIG. 6. Genomic distribution of REP2 in the three pathogenic Neisseria strains sequenced: Z2491, MC58, and FA1090. REP2 sequences on the plus strand are represented by open triangles, and REP2 sequences on the minus strand are shown by open circles. The origins of replication of neisserial strains (filled triangles) were as given elsewhere (20, 31) and verified (determined for N. gonorrhoeae) by a BLASTN search for clusters of DnaA boxes (24). The circular genome of Neisseria is replicated bidirectionally from this origin to a meeting point. Hence, the continuously synthesized leading strand (black arrows) corresponds to the plus strand (5' to 3') in the figures, to the right of the origin of replication, and to the minus strand (3' to 5') to the left. The diagrams are linear representations of the circular chromosome.
|
This work was supported by grants from the Institut National de la Santé et de la Recherche Médicale, Université Paris V-René Descartes, and the Fondation pour la Recherche Médicale.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»